The U.S. value-based healthcare service market size was exhibited at USD 4.15 trillion in 2024 and is projected to hit around USD 8.55 trillion by 2034, growing at a CAGR of 7.5% during the forecast period 2024 to 2034.
Report Coverage | Details |
Market Size in 2025 | USD 4.46 Trillion |
Market Size by 2034 | USD 8.55 Trillion |
Growth Rate From 2024 to 2034 | CAGR of 7.5% |
Base Year | 2024 |
Forecast Period | 2024-2034 |
Segments Covered | Models, Payer Category, Providers Utilization Category |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Key Companies Profiled | Baker Tilly US, LLP; Deloitte; Siemens Medical Solutions USA, Inc.; Boston Consulting Group; Change Healthcare; Athena Healthcare; Veritas Capital Fund Management, L.L.C.; UnitedHealth Group.; NXGN Management, LLC.; McKesson Corporation; Genpact; Unlimited Technology Systems, LLC; ForeSee Medical, Inc.; Signify Health, Inc. (Sentara Healthcare); Curation Health; Koninklijke Philips N.V.; Humana; The Commonwealth Fund.; Stellar Health; Privia Health. |
Burgeoning pressure on the health system due to the constant increase in healthcare spending as a percentage of GDP and healthcare delivery costs are the key contributors to the rising penetration of value-based healthcare services in the industry. There is growing potential to implement a value-based healthcare system in the U.S. due to general areas of improvement such as the need for patient-centricity and uncoordinated treatment.
Factors such as the increasing prevalence of chronic illnesses, enhanced government initiatives, and a rising demand for more cohesive care delivery systems are anticipated to drive market growth throughout the forecast period. The rising prevalence of chronic diseases within the population highlights the necessity for value-based healthcare services to reduce unnecessary healthcare expenditures, thereby driving market growth. For instance, according to Control and Prevention (CDC) updates published in November 2023, approximately 136 million people are suffering with diabetic or prediabetic issues in the U.S. Moreover, as per the National Centre for Health Statistics, as of 2022, approximately 4.6% of adults in the U.S. have ever been diagnosed with COPD, emphysema, or chronic bronchitis. This statistic highlights the prevalence of these chronic respiratory conditions within the adult population.
A significant trend in healthcare is the growing emphasis on patient-centered care models. Initiatives such as patient-reported outcomes measures (PROMs) are becoming increasingly popular, enabling healthcare providers to customize treatments based on feedback and preferences from patients. For example, the Centers for Medicare & Medicaid Services (CMS) in the United States has played a key role in advancing value-based care through initiatives like the Medicare Shared Savings Program (MSSP) and the Hospital Readmissions Reduction Program (HRRP). These programs encourage healthcare providers to minimize readmissions and enhance the quality of care.
Furthermore, in February 2023, the Department of Health and Human Services (HHS) introduced several value-based initiatives aimed at supporting rural leaders and communities. These initiatives were developed primarily through the Centers for Medicare and Medicaid Services (CMS) and its Center for Medicare and Medicaid Innovation (CMMI). The goal is to help identify HHS value-based programs that are appropriate for rural participation. It is expected that these initiatives can enhance the implementation of integrated care models to effectively manage patient diseases, which in turn is likely to drive market growth.
Moreover, there is an increasing focus on population health management, where healthcare providers prioritize preventive care and the management of chronic diseases for specific groups of patients. A study published in Health Affairs indicates that value-based care models have led to a 5.6% decrease in hospitalizations and a 9% decline in emergency department visits, underscoring their effectiveness in enhancing patient outcomes.
On the basis of models, the patient-centred medical homes segment held the largest revenue share of 31.69% in 2024 and is expected to grow at a fastest CAGR over the forecast period. The ability of patient-centered medical home services to improve efficiency while providing medical assistance and reducing medical costs is one of the key factors influencing the market expansion. In addition, this market would have significant support, as healthcare providers at both the private and public levels restructure their operations to line with value-based reimbursement and patient-centered medical home care models. For instance, Pfizer has several patient-centered medical home models with which it collaborates on care management programs (PCMH).
The shared savings segment is expected to grow at the lucrative rate over the forecast period due to growing government initiatives aimed at introducing new models and programs. Moreover, the shared savings models offer numerous benefits, such as reducing unnecessary duplication of services and minimizing medical errors. The rising efforts to engage healthcare providers as Accountable Care Organizations (ACOs) are instrumental in enhancing the sustainability of the Medicare program while ensuring that Medicare patients receive high-quality care. For instance, in January 2023, the Centers for Medicare & Medicaid Services (CMS) introduced three innovative accountable care initiatives: the Medicare Shared Savings Program, the Community Health (ACO REACH) Model, and the Kidney Care Choices (KCC) Model along with the Accountable Care Organization Realizing Equity and Access Model. These initiatives are expected to provide improved quality of care to over 13.2 million Medicare beneficiaries in 2023. Consequently, such initiatives are likely to drive growth in this segment throughout the forecast period.
On the basis of payer category, the medicare and medicare advantage segment held the largest revenue share of 48.48% in 2024 and is anticipated to grow at a fastest CAGR over the forecast period. Medicare is gradually shifting from fee-for-service compensation toward value-based models that promote cost-cutting and quality improvement, which is anticipated to drive market growth. The Medicare Advantage (MA) program, which enables Medicare beneficiaries to voluntarily join a commercial plan that provides health benefits, was established by the Balanced Budget Act (BBA) of 1997. In a related manner, the Centers for Medicare and Medicaid Services (CMS) and private insurers have enthusiastically endorsed several payment strategies for primary care doctors, specialists, and health systems in taking on financial risk for the individuals they treat.
The Medicaid segment is expected to grow at the fastest CAGR over the forecast period. This growth is attributed to the increasing number of individuals qualifying for Medicaid, driven by economic challenges and expanded eligibility criteria under the Affordable Care Act (ACA), is creating a more extensive patient base that requires comprehensive healthcare services. As states continue to expand Medicaid programs, more low-income individuals gain access to essential health services, aligning with value-based care principles that emphasize quality over quantity. Moreover, there is a growing recognition of social determinants of health (SDOH) and their impact on patient outcomes. Medicaid programs are increasingly incorporating SDOH into their frameworks, focusing on holistic approaches that address medical needs and social factors such as housing, nutrition, and transportation. This shift encourages providers to adopt value-based care models that incentivize improved health outcomes rather than increased service utilization.
On the basis of service, the self-care segment held the largest revenue share of 38.0% in 2024. Its dominance is due to increasing emphasis on patient-centered care, encouraging individuals to manage their health actively. This shift aligns with the principles of value-based care, where outcomes are prioritized over the volume of services provided. As patients become more empowered and informed about their health conditions, they are more likely to seek out self-care options, including telehealth services, mobile health applications, and wellness programs that promote preventive care. Moreover, the shift from fee-for-service models to value-based payment systems incentivizes healthcare providers to focus on preventive care and chronic disease management. Insurers increasingly recognize the importance of supporting self-care initiatives through coverage for digital health solutions and wellness programs.
The institutional care segment is expected to grow at the fastest CAGR over the forecast period. Its growth is attributed to the increasing technology, operational problems, rising consumer expectations, and new health conditions. As a result, there has been a continuous shift toward healthcare services that are value-based and patient-centered. Due to profitability, the number of patients treated, lower financial risk, value-based healthcare services are driven by a focus on establishing integrated practice units, which measure outcomes and cost at the patient level, bundle prices, geographic expansion, and information technology platforms.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. value-based healthcare service market
Models
Payer Category
Providers Utilization Category
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
1.9. List of Secondary Sources
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. U.S. Value-based Healthcare Service Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Model segment outlook
2.1.2.2. Payer category segment outlook
2.1.2.3. Providers utilization category outlook
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising Incidence of Chronic Diseases and Increasing Government Initiatives
3.3.1.2. Growing Demand for More Integrated Care Delivery Models
3.3.2. Market Restraint Analysis
3.3.2.1. Challenges in Balancing Two Reimbursement Types and Payment
3.4. Regulatory Framework
3.5. Business Environment Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces Analysis
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
Chapter 4. Models Business Analysis
4.1. U.S. Value-based Healthcare Service Market: Models Movement Analysis
4.2. U.S. Value-based Healthcare Service Market: Models Segment Dashboard
4.3. Models Movement & Market Share Analysis, 2024 & 2034
4.4. U.S. Value-based Healthcare Service Market Estimates & Forecast, by Models
4.5. Pay For Performance
4.5.1. Pay for performance market, 2021 - 2034 (USD Billion)
4.6. Patient-Centered Medical Home
4.6.1. Patient-centered medical home market, 2021 - 2034 (USD Billion)
4.7. Shared Savings
4.7.1. Shared savings market, 2021 - 2034 (USD Billion)
4.8. Shared Risk
4.8.1. Shared risk market, 2021 - 2034 (USD Billion)
4.9. Bundled Payment
4.9.1. Bundled payment market, 2021 - 2034 (USD Billion)
4.10. Capitation Models
4.10.1. Capitation models market, 2021 - 2034 (USD Billion)
Chapter 5. Payer Category Business Analysis
5.1. U.S. Value-based Healthcare Service Market: Payer Category Movement Analysis
5.2. U.S. Value-based Healthcare Service Market: Payer Category Segment Dashboard
5.3. Payer Category Movement & Market Share Analysis, 2024 & 2034
5.4. U.S. Value-based Healthcare Service Market Estimates & Forecast, by Payer Category
5.5. Medicare and Medicare Advantage
5.5.1. Medicare and medicare advantage market, 2021 - 2034 (USD Billion)
5.6. Medicaid
5.6.1. Medicaid market, 2021 - 2034 (USD Billion)
5.7. Commercial
5.7.1. Commercial market, 2021 - 2034 (USD Billion)
Chapter 6. Providers Utilization Category Business Analysis
6.1. U.S. Value-based Healthcare Service Market: Providers Utilization Category Movement Analysis
6.2. U.S. Value-based Healthcare Service Market: Providers Utilization Category Segment Dashboard
6.3. Providers Utilization Category Movement & Market Share Analysis, 2024 & 2034
6.4. U.S. Value-based Healthcare Service Market Estimates & Forecast, by Providers Utilization Category
6.5. Home Health Care
6.5.1. Home health care market, 2021 - 2034 (USD Billion)
6.5.2. Frontloading skilled nursing visits
6.5.2.1. Frontloading skilled nursing visits market, 2021 - 2034 (USD Billion)
6.5.3. Specialized frontloading therapy visits
6.5.3.1. Specialized frontloading therapy visits market, 2021 - 2034 (USD Billion)
6.6. Institutional Care
6.6.1. Institutional care market, 2021 - 2034 (USD Billion)
6.7. Self-Care
6.7.1. Self-care market, 2021 - 2034 (USD Billion)
6.8. Hospital Therapy
6.8.1. Hospital therapy market, 2021 - 2034 (USD Billion)
6.8.2. InPatient
6.8.2.1. InPatient market, 2021 - 2034 (USD Billion)
6.8.3. Outpatient
6.8.3.1. Outpatient market, 2021 - 2034 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Position Analysis
7.3. Strategy Mapping
7.3.1. Partnership/Collaboration/Alliance
7.3.2. New Product Launch
7.3.3. Mergers & Acquisitions
7.3.4. Others
7.4. Company Profiles/Listing
7.4.1. Baker Tilly US, LLP
7.4.1.1. Overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Deloitte
7.4.2.1. Overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Siemens Medical Solutions USA, Inc.
7.4.3.1. Overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Boston Consulting Group
7.4.4.1. Overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Change Healthcare
7.4.5.1. Overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Athena Healthcare
7.4.6.1. Overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Veritas Capital Fund Management, L.L.C.
7.4.7.1. Overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. UnitedHealth Group.
7.4.8.1. Overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. NXGN Management, LLC.
7.4.9.1. Overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. McKesson Corporation
7.4.10.1. Overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Genpact
7.4.11.1. Overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Unlimited Technology Systems, LLC
7.4.12.1. Overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. ForeSee Medical, Inc.
7.4.13.1. Overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
7.4.14. Signify Health, Inc. (Sentara Healthcare)
7.4.14.1. Overview
7.4.14.2. Financial performance
7.4.14.3. Product benchmarking
7.4.14.4. Strategic initiatives
7.4.15. Curation Health
7.4.15.1. Overview
7.4.15.2. Financial performance
7.4.15.3. Product benchmarking
7.4.15.4. Strategic initiatives
7.4.16. Koninklijke Philips N.V.
7.4.16.1. Overview
7.4.16.2. Financial performance
7.4.16.3. Product benchmarking
7.4.16.4. Strategic initiatives
7.4.17. Humana
7.4.17.1. Overview
7.4.17.2. Financial performance
7.4.17.3. Product benchmarking
7.4.17.4. Strategic initiatives
7.4.18. The Commonwealth Fund.
7.4.18.1. Overview
7.4.18.2. Financial performance
7.4.18.3. Product benchmarking
7.4.18.4. Strategic initiatives
7.4.19. Stellar Health
7.4.19.1. Overview
7.4.19.2. Financial performance
7.4.19.3. Product benchmarking
7.4.19.4. Strategic initiatives
7.4.20. Privia Health
7.4.20.1. Overview
7.4.20.2. Financial performance
7.4.20.3. Product benchmarking
7.4.20.4. Strategic initiatives